Local view for "http://purl.org/linkedpolitics/eu/plenary/2010-11-24-Speech-3-131"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2010-11-24"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"pl"^^xsd:language2
lpv:document identification number	"en.20101124.15.3-131"2
lpv:hasSubsequent	lp_eu:2010-11-24-Speech-3-1322
lpv:speaker	lp:Jarosław Kalinowski2
lpv:spokenAs	member; AGRI (2009-07-16--2012-01-18)3 member; Delegation to the Euronest Parliamentary Assembly (2009-09-16--2012-03-27)3 substitute; Delegation for relations with the Pan-African Parliament (2009-09-16--2014-06-30)3 substitute; ENVI (2009-07-16--2012-01-18)3 member; EPP (2009-07-14--2014-06-30)3 unknown; Polskie Stronnictwo Ludowe (2009-07-14--2014-06-30)3 substitute; Delegation to the EU-Kazakhstan, EU-Kyrgyzstan and EU-Uzbekistan Parliamentary Cooperation Committees, and for relations with Tajikistan, Turkmenistan and Mongolia (2009-09-16--2014-06-30)3 member; Delegation for relations with Belarus (2009-09-16--2012-03-27)3
lpv:translated text	"Mr President, to protect public health effectively, it is essential to ensure patients have extensive access to high quality information about medicines. Harmonisation of the law in this field will allow us to ensure a high level of awareness among European patients and will help to even out differences in the health situation in all Member States. In addition, making legislation more detailed, and in particular the obligation to ensure that patients have access to information, will allow us to prevent pharmaceutical companies from unfairly promoting their own products. Currently, this procedure is not adequately supervised. It is also necessary to introduce particular legislation concerning pharmaceutical agents and to enforce its implementation effectively in all Member States. I endorsed the report."@en1
lpv:videoURI	<go to Events_and_structure europarl>2

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph